Vectura Group plc announced the appointment of Anne Whitaker as an Independent Non-Executive Director of the company with effect from 1 June 2018. Anne has more than 25 years of experience in the life science industry, including senior leadership roles with large pharmaceutical, biotech, and speciality pharma companies. She has significant experience in the U.S. respiratory sector and was, until recently, serving as President and Chief Executive Officer of KNOW Bio, LLC and its wholly owned subsidiary, Novoclem Therapeutics Inc. Anne is currently an Independent Director of Cree Inc. and has been nominated to serve as an independent director of Mallinckrodt plc pending their shareholder vote at the Annual General Meeting in May, 2018.